The DOI matches its Crossref record; 177 of the 177 references it cites were found in a registry or an index.
Nanoparticles for nasal vaccination
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Immunobiology of Dendritic Cells
Banchereau, J., Briere, F., Caux, C., Davoust, J., Lebecque, S., Liu, Y.-J., Pulendran, B., & Palucka, K. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.767 · Cited by 6,634
A Toll-like receptor recognizes bacterial DNA
Hemmi, H., Takeuchi, O., Kawai, T., Kaisho, T., Sato, S., Sanjo, H., Matsumoto, M., Hoshino, K., Wagner, H., Takeda, K., et al. (2000) · Nature · doi:10.1038/35047123 · Cited by 6,491 · cited 2×
“Examples of adjuvants that enhance costimulatory signaling by presenting foreign/danger signals are: Freund’s adjuvant, certain oligonucleotide sequences such as CpG, double stranded RNA such as poly I:C, bacterial lipopolysaccarides, monophosphoryl lipid A, and mannose [76-79].”
BackgroundRecognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3
Alexopoulou, L., Holt, A. C., Medzhitov, R., & Flavell, R. A. (2001) · Nature · doi:10.1038/35099560 · Cited by 6,129
Toll-like receptors: critical proteins linking innate and acquired immunity
Akira, S., Takeda, K., & Kaisho, T. (2001) · Nature Immunology · doi:10.1038/90609 · Cited by 4,777
Toll-like receptors in the induction of the innate immune response
Aderem, A., & Ulevitch, R. J. (2000) · Nature · doi:10.1038/35021228 · Cited by 3,064
Biodegradable Long-Circulating Polymeric Nanospheres
Gref, R., Minamitake, Y., Peracchia, M. T., Trubetskoy, V., Torchilin, V., & Langer, R. (1994) · Science · doi:10.1126/science.8128245 · Cited by 2,920
Markowitz, L. E., Dunne, E. F., Saraiya, M., Lawson, H. W., Chesson, H., & Unger, E. R. (2007) · PsycEXTRA Dataset · doi:10.1037/e601292007-001 · Cited by 1,882
Molecular identification of a danger signal that alerts the immune system to dying cells
Shi, Y., Evans, J. E., & Rock, K. L. (2003) · Nature · doi:10.1038/nature01991 · Cited by 1,684
Differential Antigen Processing by Dendritic Cell Subsets in Vivo
Dudziak, D., Kamphorst, A. O., Heidkamp, G. F., Buchholz, V. R., Trumpfheller, C., Yamazaki, S., Cheong, C., Liu, K., Lee, H.-W., Park, C. G., et al. (2007) · Science · doi:10.1126/science.1136080 · Cited by 1,455
Mucosal vaccines: the promise and the challenge
Neutra, M. R., & Kozlowski, P. A. (2006) · Nature Reviews Immunology · doi:10.1038/nri1777 · Cited by 1,223
The basics and underlying mechanisms of mucoadhesion
SMART, J. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.07.001 · Cited by 1,167
Chitosan microspheres as a potential carrier for drugs
Sinha, V. R., Singla, A. K., Wadhawan, S., Kaushik, R., Kumria, R., Bansal, K., & Dhawan, S. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2003.12.026 · Cited by 1,128
Romagnani, S. (1997) · Immunology Today · doi:10.1016/s0167-5699(97)80019-9 · Cited by 1,078
Mucus clearance as a primary innate defense mechanism for mammalian airways
Knowles, M. R., & Boucher, R. C. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215217 · Cited by 1,054
Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus
Lai, S. K., O'Hanlon, D. E., Harrold, S., Man, S. T., Wang, Y.-Y., Cone, R., & Hanes, J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608611104 · Cited by 1,050
Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology
Asselin-Paturel, C., Boonstra, A., Dalod, M., Durand, I., Yessaad, N., Dezutter-Dambuyant, C., Vicari, A., O'Garra, A., Biron, C., Brière, F., et al. (2001) · Nature Immunology · doi:10.1038/ni736 · Cited by 1,022
Distinct dendritic cell subsets differentially regulate the class of immune response invivo
Pulendran, B., Smith, J. L., Caspary, G., Brasel, K., Pettit, D., Maraskovsky, E., & Maliszewski, C. R. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.3.1036 · Cited by 991
Polysaccharide colloidal particles as delivery systems for macromolecules
Janes, K. A., Calvo, P., & Alonso, M. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00123-x · Cited by 900
Self-citationCalvo, P., Remuñan-López, C., Vila-Jato, J. L., & Alonso, M. J. (1997) · Pharmaceutical Research · doi:10.1023/a:1012128907225 · Cited by 817
Self-citationFu, K., Pack, D. W., Klibanov, A. M., & Langer, R. (2000) · Pharmaceutical Research · doi:10.1023/a:1007582911958 · Cited by 764
Chitosan as a novel nasal delivery system for vaccines
Illum, L., Jabbal-Gill, I., Hinchcliffe, M., Fisher, A. N., & Davis, S. S. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00171-5 · Cited by 755
PLGA Nanoparticles in Drug Delivery: The State of the Art;
Bala, I., Hariharan, S., & Kumar, M. R. (2004) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v21.i5.20 · Cited by 739
Iscom, a novel structure for antigenic presentation of membrane proteins from enveloped viruses
Morein, B., Sundquist, B., Höglund, S., Dalsgaard, K., & Osterhaus, A. (1984) · Nature · doi:10.1038/308457a0 · Cited by 708
Liposomes as immunological adjuvants
ALLISON, A. C., & GREGORIADIS, G. (1974) · Nature · doi:10.1038/252252a0 · Cited by 675
Design of biodegradable particles for protein delivery
Vila, A., Sánchez, A., Tobı́o, M., Calvo, P., & Alonso, M. J. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00486-2 · Cited by 620
Self-citationEnhancement of Nasal Absorption of Insulin Using Chitosan Nanoparticles
Fernández-Urrusuno, R., Calvo, P., Remuñán-López, C., Vila-Jato, J. L., & José Alonso, M. (1999) · Pharmaceutical Research · doi:10.1023/a:1018908705446 · Cited by 587
Adjuvant-Enhanced Antibody Responses in the Absence of Toll-Like Receptor Signaling
Gavin, A. L., Hoebe, K., Duong, B., Ota, T., Martin, C., Beutler, B., & Nemazee, D. (2006) · Science · doi:10.1126/science.1135299 · Cited by 581
Nanotechnology in vaccine delivery
Peek, L. J., Middaugh, C. R., & Berkland, C. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.05.017 · Cited by 562
Nasal mucoadhesive drug delivery: Background, applications, trends and future perspectives
UGWOKE, M., AGU, R., VERBEKE, N., & KINGET, R. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.07.009 · Cited by 543
Iwasaki, A. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141634 · Cited by 534
Kunkel, E. J., & Butcher, E. C. (2003) · Nature Reviews Immunology · doi:10.1038/nri1203 · Cited by 532
Aguilar, J. C., & Rodríguez, E. G. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.01.111 · Cited by 494
Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice
Vila, A., Sánchez, A., Janes, K., Behrens, I., Kissel, T., Jato, J. L. V., & Alonso, M. J. (2004) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2003.09.006 · Cited by 449
Self-citationIs nose-to-brain transport of drugs in man a reality?
Illum, L. (2004) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357022539 · Cited by 439
Recent advances in the discovery and delivery of vaccine adjuvants
O'Hagan, D. T., & Valiante, N. M. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1176 · Cited by 434
Li, M., Carpio, D. F., Zheng, Y., Bruzzo, P., Singh, V., Ouaaz, F., Medzhitov, R. M., & Beg, A. A. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.12.7128 · Cited by 432
INTERACTION OF ANTIGENS AND ANTIBODIES AT MUCOSAL SURFACES
Lamm, M. E. (1997) · Annual Review of Microbiology · doi:10.1146/annurev.micro.51.1.311 · Cited by 429
Permeability issues in nasal drug delivery
Arora, P., Sharma, S., & Garg, S. (2002) · Drug Discovery Today · doi:10.1016/s1359-6446(02)02452-2 · Cited by 426
Amidi, M., Romeijn, S. G., Borchard, G., Junginger, H. E., Hennink, W. E., & Jiskoot, W. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.11.014 · Cited by 415
Stealth PLA-PEG nanoparticles as protein carriers for nasal administration
Tobío, M., Gref, R., Sánchez, A., Langer, R., & Alonso, M. J. (1998) · Pharmaceutical Research · doi:10.1023/a:1011922819926 · Cited by 402
Self-citationAntibody diffusion in human cervical mucus
Saltzman, W. M., Radomsky, M. L., Whaley, K. J., & Cone, R. A. (1994) · Biophysical Journal · doi:10.1016/s0006-3495(94)80802-1 · Cited by 381
Behrens, I., Pena, A. I. V., Alonso, M. J., & Kissel, T. (2002) · Pharmaceutical Research · doi:10.1023/a:1019854327540 · Cited by 372
Self-citationTobı́o, M., Sánchez, A., Vila, A., Soriano, I., Evora, C., Vila-Jato, J. L., & Alonso, M. J. (2000) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/s0927-7765(99)00157-5 · Cited by 368
Self-citationThe biopharmaceutical aspects of nasal mucoadhesive drug delivery
Ugwoke, M. I., Verbeke, N., & Kinget, R. (2001) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357011775145 · Cited by 355
Islet Regeneration During the Reversal of Autoimmune Diabetes in NOD Mice
Kodama, S., Kühtreiber, W., Fujimura, S., Dale, E. A., & Faustman, D. L. (2003) · Science · doi:10.1126/science.1088949 · Cited by 355
Anatomy, physiology and function of the nasal cavities in health and disease
Mygind, N., & Dahl, R. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00058-6 · Cited by 344
Transmucosal macromolecular drug delivery
Prego, C., García, M., Torres, D., & Alonso, M. J. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.07.030 · Cited by 338
Self-citationImmunity in response to particulate antigen-delivery systems
STORNI, T., KUNDIG, T., SENTI, G., & JOHANSEN, P. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.09.008 · Cited by 317
Formulation aspects of biodegradable polymeric microspheres for antigen delivery
TAMBER, H., JOHANSEN, P., MERKLE, H., & GANDER, B. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.09.002 · Cited by 316
Transcytosis of nanoparticle and dendrimer delivery systems: evolving vistas
Florence, A. T., & Hussain, N. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00184-3 · Cited by 308
Saponins as vaccine adjuvants.
Kensil, C. R. (1996) · PubMed · Cited by 296
Gutierro, I., Hernández, R. M., Igartua, M., Gascón, A. R., & Pedraz, J. L. (2002) · Vaccine · doi:10.1016/s0264-410x(02)00435-8 · Cited by 292
Roldo, M., Hornof, M., Caliceti, P., & Bernkop‐Schnürch, A. (2003) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(03)00157-7 · Cited by 292
Liposomes as carriers of enzymes or drugs: a new approach to the treatment of storage diseases
Gregoriadis, G., & Ryman, B. E. (1971) · Biochemical Journal · doi:10.1042/bj1240058p · Cited by 286
IFNs activate toll-like receptor gene expression in viral infections
Miettinen, M., Sareneva, T., Julkunen, I., & Matikainen, S. (2001) · Genes & Immunity · doi:10.1038/sj.gene.6363791 · Cited by 282
Cholera toxin induces maturation of human dendritic cells and licences them for Th2 priming
Gagliardi, M. C., Sallusto, F., Marinaro, M., Langenkamp, A., Lanzavecchia, A., & De Magistris, M. T. (2000) · European Journal of Immunology · doi:10.1002/1521-4141(2000)30:8<2394::aid-immu2394>3.0.co;2-y · Cited by 278
Th1- and Th2-cell commitment during infectious disease: asymmetry in divergent pathways
Jankovic, D., Liu, Z., & Gause, W. C. (2001) · Trends in Immunology · doi:10.1016/s1471-4906(01)01975-5 · Cited by 275
Vila, A., Gill, H., McCallion, O., & Alonso, M. J. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.04.026 · Cited by 249
Self-citationAmidi, M., Romeijn, S. G., Verhoef, J. C., Junginger, H. E., Bungener, L., Huckriede, A., Crommelin, D. J. A., & Jiskoot, W. (2007) · Vaccine · doi:10.1016/j.vaccine.2006.06.086 · Cited by 247
Exploiting M cells for drug and vaccine delivery
Clark, M. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00149-1 · Cited by 246
Nanoparticulate Systems for Nasal Delivery of Drugs: A Real Improvement over Simple Systems?
Illum, L. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20718 · Cited by 237
Storm, G., & Crommelin, D. J. A. (1998) · Pharmaceutical Science & Technology Today · doi:10.1016/s1461-5347(98)00007-8 · Cited by 224
Chitosan/cyclodextrin nanoparticles as macromolecular drug delivery system
KRAULAND, A., & ALONSO, M. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.03.005 · Cited by 222
Self-citationLocalization dose and time of antigens determine immune reactivity
Zinkernagel, R. M. (2000) · Seminars in Immunology · doi:10.1006/smim.2000.0253 · Cited by 214
Nasal Route for Direct Delivery of Solutes to the Central Nervous System: Fact or Fiction?
Mathison, S., Nagilla, R., & Kompella, U. B. (1998) · Journal of Drug Targeting · doi:10.3109/10611869808997870 · Cited by 200
Enhanced: The Need for a Global HIV Vaccine Enterprise
Klausner, R. D., Fauci, A. S., Corey, L., Nabel, G. J., Gayle, H., Berkley, S., Haynes, B. F., Baltimore, D., Collins, C., Douglas, R. G., et al. (2003) · Science · doi:10.1126/science.1086916 · Cited by 197
Bronchus‐ and nasal‐associated lymphoid tissues
Bienenstock, J., & McDermott, M. R. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00299.x · Cited by 197
Fenart, L., Casanova, A., Dehouck, B., Duhem, C., Slupek, S., Cecchelli, R., & Betbeder, D. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35204-8 · Cited by 196
Uptake of poly(D,L‐lactic‐co‐glycolic acid) microspheres by antigen‐presenting cells in vivo
Newman, K. D., Elamanchili, P., Kwon, G. S., & Samuel, J. (2002) · Journal of Biomedical Materials Research · doi:10.1002/jbm.10019 · Cited by 195
Effective nasal influenza vaccine delivery using chitosan
Read, R. C., Naylor, S. C., Potter, C. W., Bond, J., Jabbal-Gill, I., Fisher, A., Illum, L., & Jennings, R. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.04.021 · Cited by 194
Polyhydroxyalkanonate derivatives in current clinical applications and trials
Ueda, H., & Tabata, Y. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(03)00037-1 · Cited by 187
Karrer, U., Althage, A., Odermatt, B., Roberts, C. W. M., Korsmeyer, S. J., Miyawaki, S., Hengartner, H., & Zinkernagel, R. M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.12.2157 · Cited by 186
Thiolated Chitosan/DNA Nanocomplexes Exhibit Enhanced and Sustained Gene Delivery
Lee, D., Zhang, W., Shirley, S. A., Kong, X., Hellermann, G. R., Lockey, R. F., & Mohapatra, S. S. (2007) · Pharmaceutical Research · doi:10.1007/s11095-006-9136-9 · Cited by 178
Sayın, B., Somavarapu, S., Li, X. W., Thanou, M., Sesardic, D., Alpar, H. O., & Şenel, S. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.06.029 · Cited by 178
Jung, T., Kamm, W., Breitenbach, A., Hungerer, K.-D., Hundt, E., & Kissel, T. (2001) · Pharmaceutical Research · doi:10.1023/a:1011063232257 · Cited by 177
Fully mobilizing host defense: Building better vaccines
Raychaudhuri, S., & Rock, K. L. (1998) · Nature Biotechnology · doi:10.1038/3469 · Cited by 175
Pérez, C., Castellanos, I. J., Costantino, H. R., Al-Azzam, W., & Griebenow, K. (2002) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357021778448 · Cited by 175
Nair, S., Zhou, F., Reddy, R., Huang, L., & Rouse, B. T. (1992) · The Journal of experimental medicine · doi:10.1084/jem.175.2.609 · Cited by 175
Fehr, T., Skrastina, D., Pumpens, P., & Zinkernagel, R. M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9477 · Cited by 172
Garcia-Fuentes, M., Prego, C., Torres, D., & Alonso, M. J. (2005) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.02.008 · Cited by 171
Self-citationLutsiak, M. E. C., Robinson, D. R., Coester, C., Kwon, G. S., & Samuel, J. (2002) · Pharmaceutical Research · doi:10.1023/a:1020452531828 · Cited by 163
The Intangible Value of Vaccination
Rappuoli, R., Miller, H. I., & Falkow, S. (2002) · Science · doi:10.1126/science.1075173 · Cited by 163
Nasal-associated lymphoid tissue (NALT): frequency and localization in young children
DEBERTIN, A. S., TSCHERNIG, T., TÖNJES, H., KLEEMANN, W. J., TRÖGER, H. D., & PABST, R. (2003) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2003.02311.x · Cited by 163
Biodegradable micro- and nanoparticles as long-term delivery vehicles for interferon-alpha
Sánchez, A., Tobı́o, M., González, L., Fabra, A., & Alonso, M. J. (2003) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(03)00019-8 · Cited by 162
Self-citationPre-Clinical Evaluation of a Novel Nanoemulsion-Based Hepatitis B Mucosal Vaccine
Makidon, P. E., Bielinska, A. U., Nigavekar, S. S., Janczak, K. W., Knowlton, J., Scott, A. J., Mank, N., Cao, Z., Rathinavelu, S., Beer, M. R., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002954 · Cited by 159
Borges, O., Cordeiro-da-Silva, A., Tavares, J., Santarém, N., de Sousa, A., Borchard, G., & Junginger, H. E. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.01.019 · Cited by 158
Kersten, G. F. A. (2003) · Vaccine · doi:10.1016/s0264-410x(02)00540-6 · Cited by 156
PLGA:Poloxamer and PLGA:Poloxamine Blend Nanoparticles: New Carriers for Gene Delivery
Csaba, N., Caamaño, P., Sánchez, A., Domínguez, F., & Alonso, M. J. (2004) · Biomacromolecules · doi:10.1021/bm049577p · Cited by 150
Self-citationPLA-PEG particles as nasal protein carriers: the influence of the particle size
Vila, A., Sánchez, A., Évora, C., Soriano, I., McCallion, O. N. M., & Alonso, M. J. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.09.002 · Cited by 150
Self-citationKumar, M., Behera, A. K., Lockey, R. F., Zhang, J., Bhullar, G., de la Cruz, C. P., Chen, L., Leong, K. W., Huang, S.-K., & Mohapatra, S. S. (2002) · Human Gene Therapy · doi:10.1089/10430340260185058 · Cited by 146
Nanoparticles as carriers for nasal vaccine delivery
Köping‐Höggård, M., Sánchez, A., & Alonso, M. J. (2005) · Expert Review of Vaccines · doi:10.1586/14760584.4.2.185 · Cited by 143
Self-citationPlasmid DNA loaded chitosan nanoparticles for nasal mucosal immunization against hepatitis B
Khatri, K., Goyal, A. K., Gupta, P. N., Mishra, N., & Vyas, S. P. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.11.027 · Cited by 140
Glück, U., Gebbers, J., & Glück, R. (1999) · Journal of Virology · doi:10.1128/jvi.73.9.7780-7786.1999 · Cited by 137
Nagamoto, T., Hattori, Y., Takayama, K., & Maitani, Y. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000022414.17183.58 · Cited by 136
Iqbal, M., Lin, W., Jabbal‐Gill, I., Davis, S. S., Steward, M. W., & Illum, L. (2003) · Vaccine · doi:10.1016/s0264-410x(02)00662-x · Cited by 136
Waite, D. C., Jacobson, E. W., Ennis, F. A., Edelman, R., White, B., Kammer, R. B., Anderson, C., & Kensil, C. R. (2001) · Vaccine · doi:10.1016/s0264-410x(01)00142-6 · Cited by 133
A new drug nanocarrier consisting of chitosan and hydoxypropylcyclodextrin
Maestrelli, F., García-Fuentes, M., Mura, P., & Alonso, M. J. (2006) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2005.12.006 · Cited by 133
Self-citationA retrospective review of lesions associated with the use of Freund's adjuvant.
Broderson (1989) · PubMed · Cited by 133
Hamman, J. H., Stander, M. W., & Kotzé, A. F. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00914-0 · Cited by 132
M cell targeting by lectins: a strategy for mucosal vaccination and drug delivery
Jepson, M. A., Clark, M. A., & Hirst, B. H. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.018 · Cited by 130
Complement and innate immunity
Song, W.-C., Sarrias, M., & Lambris, J. D. (2000) · Immunopharmacology · doi:10.1016/s0162-3109(00)80303-3 · Cited by 129
Jabbal‐Gill, I., Fisher, A. N., Rappuoli, R., Davis, S. S., & Illum, L. (1998) · Vaccine · doi:10.1016/s0264-410x(98)00077-2 · Cited by 129
The performance of nanocarriers for transmucosal drug delivery
Csaba, N., García-Fuentes, M., & Alonso, M. J. (2006) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.3.4.463 · Cited by 127
Self-citationPLGA: Poloxamer and PLGA: Poloxamine blend nanostructures as carriers for nasal gene delivery
Csaba, N., Sánchez, A., & Alonso, M. J. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.03.017 · Cited by 120
Self-citationSurface modified liposomes for nasal delivery of DNA vaccine
Khatri, K., Goyal, A. K., Gupta, P. N., et al. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.02.058 · Cited by 120
Chitosan and the mucosal delivery of biotechnology drugs
Issa, M. M., Köping‐Höggård, M., & Artursson, P. (2005) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2005.05.008 · Cited by 120
Immune responses to ISCOM® formulations in animal and primate models
Sjölander, A., Drane, D. P., Maraskovsky, E., Scheerlinck, J. Y., Suhrbier, A., Tennent, J. M., & Pearse, M. J. (2001) · Vaccine · doi:10.1016/s0264-410x(00)00497-7 · Cited by 117
Almeida, A. J., Alpar, H. O., & Brown, M. R. (1993) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1993.tb05532.x · Cited by 116
Akagi, T., Baba, M., & Akashi, M. (2007) · Polymer · doi:10.1016/j.polymer.2007.08.038 · Cited by 116
PEG-PLA Nanoparticles as Carriers for Nasal Vaccine Delivery
Vila, A., Sánchez, A., Évora, C., Soriano, I., Jato, J. L. V., & Alonso, M. J. (2004) · Journal of Aerosol Medicine · doi:10.1089/0894268041457183 · Cited by 115
Self-citationChitosan/cyclodextrin nanoparticles can efficiently transfect the airway epithelium in vitro
Teijeiro‐Osorio, D., Remuñán‐López, C., & Alonso, M. J. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.09.020 · Cited by 110
Self-citationDailey, L. A., Wittmar, M., & Kissel, T. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.09.003 · Cited by 108
Debin, A., Kravtzoff, R., Santiago, J. V., Cazales, L., Spérandio, S., Melber, K., Janowicz, Z. A., Betbeder, D., & Moynier, M. (2002) · Vaccine · doi:10.1016/s0264-410x(02)00191-3 · Cited by 108
Rosada, R. S., de la Torre, L. G., Frantz, F. G., Trombone, A. P. F., Zárate-Bladés, C. R., da Fonseca, D. M., Souza, P., Brandão, I. T., Masson, A. P., Soares, E. G., et al. (2008) · BMC Immunology · doi:10.1186/1471-2172-9-38 · Cited by 107
Iscoms Containing PurifiedQuillajaSaponins Upregulate both Th1-like and Th2-like Immune Responses
Sjölander, A., Land, B. V., & Bengtsson, K. L. (1997) · Cellular Immunology · doi:10.1006/cimm.1997.1088 · Cited by 106
Prevention of Peripheral Tolerance by a Dendritic Cell Growth Factor: Flt3 Ligand as an Adjuvant
Pulendran, B., Smith, J. L., Jenkins, M. K., et al. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.11.2075 · Cited by 106
Joseph, A., Itskovitz-Cooper, N., Samira, S., Flasterstein, O., Eliyahu, H., Simberg, D., Goldwaser, I., Barenholz, Y., & Kedar, E. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.12.017 · Cited by 105
Akagi, T., Higashi, M., Kaneko, T., Kida, T., & Akashi, M. (2005) · Biomacromolecules · doi:10.1021/bm050657i · Cited by 101
Alonso-Sande, M., Cuña, M., Remuñán‐López, C., et al. (2006) · Macromolecules · doi:10.1021/ma060230j · Cited by 100
Boonyo, W., Junginger, H. E., Waranuch, N., Polnok, A., & Pitaksuteepong, T. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.05.025 · Cited by 98
Aramaki, Y., Tomizawa, H., Hara, T., Yachi, K., Kikuchi, H., & TSUCHIYA, S. (1993) · Pharmaceutical Research · doi:10.1023/a:1018936806278 · Cited by 97
Toll-like receptors and antibody responses
Nemazee, D. A., Gavin, A. L., Hoebe, K. H. N., & Beutler, B. (2006) · Nature · doi:10.1038/nature04875 · Cited by 97
Jódar, L., LaForce, F. M., Ceccarini, C., Aguado, T., & Granoff, D. M. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13494-0 · Cited by 96
Branched biodegradable polyesters for parenteral drug delivery systems
Breitenbach, A., Li, Y. X., & Kissel, T. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00134-0 · Cited by 92
de Haan, A., Geerligs, H. J., Huchshorn, J. P., Scharrenburg, G. J. M. V., Palache, A. M., & Wilschut, J. (1995) · Vaccine · doi:10.1016/0264-410x(95)93129-w · Cited by 91
Fernández‐Urrusuno, R., Romani, D., Calvo, P., Vila-Jato, J. L., & Alonso, M. J. (1999) · Stp Pharma Sciences · Cited by 90
Self-citationM Cells in Antigen Sampling in Mucosal Tissues
Neutra, M. R. (1999) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-59951-4_2 · Cited by 89
Induction of Th1 and Th2 CD4+ T cell responses by oral or parenteral immunization with ISCOMS
Maloy, K. J., Donachie, A. M., & Mowat, A. M. (1995) · European Journal of Immunology · doi:10.1002/eji.1830251019 · Cited by 87
Novel drug nanocarriers combining hydrophilic cyclodextrins and chitosan
Trapani, A., García-Fuentes, M., & Alonso, M. J. (2008) · Nanotechnology · doi:10.1088/0957-4484/19/18/185101 · Cited by 86
Self-citationMarchisio, P., Cavagna, R., Maspes, B., Gironi, S., Esposito, S., Lambertini, L., Massimini, A., Herzog, C., & Principi, N. (2002) · Clinical Infectious Diseases · doi:10.1086/341028 · Cited by 83
Hu, K., Elvander, M., Mérza, M., Åkerblom, L., Brandenburg, A. H., & Morein, B. (1998) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.1998.00650.x · Cited by 82
Sakaue, G., Hiroi, T., Nakagawa, Y., Someya, K., Iwatani, K., Sawa, Y., Takahashi, H., Honda, M., Kunisawa, J., & Kiyono, H. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.1.495 · Cited by 79
Ochsenbein, A. F., Pinschewer, D. D., Odermatt, B., Ciurea, A., Hengartner, H., & Zinkernagel, R. M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.12.6296 · Cited by 79
Shibata, Y., Honda, I., Justice, J. P., et al. (2001) · Infection and Immunity · doi:10.1128/iai.69.10.6123-6130.2001 · Cited by 78
Ensuring vaccine safety in immunization programmes — a WHO perspective
Jódar, L., DUCLOS, P. J., Milstien, J. B., Griffiths, E., Aguado, M. T., & Clements, C. J. (2001) · Vaccine · doi:10.1016/s0264-410x(00)00358-3 · Cited by 75
Baca‐Estrada, M. E., Földvári, M., Snider, M., Harding, K. M., Kournikakis, B., Babiuk, L. A., & Griebel, P. J. (2000) · Vaccine · doi:10.1016/s0264-410x(00)00019-0 · Cited by 72
Mucosal antibody response induced with a nasal virosome-based influenza vaccine
Durrer, P. (2003) · Vaccine · doi:10.1016/s0264-410x(03)00457-2 · Cited by 71
Sanders, N. N., Smedt, S. C. D., & Demeester, J. (2000) · Journal of Pharmaceutical Sciences · doi:10.1002/1520-6017(200007)89:7<835::aid-jps1>3.0.co;2-6 · Cited by 70
UGOZZOLI, O’HAGAN, & OTT (1998) · Immunology · doi:10.1046/j.1365-2567.1998.00441.x · Cited by 69
Lipid microparticles for mucosal immunization against hepatitis B
Saraf, S., Mishra, D. K., Asthana, A., Jain, R., Singh, S., & Jain, N. K. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.07.053 · Cited by 69
Csaba, N., Köping‐Höggård, M., Fernández-Megía, E., et al. (2009) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2009.1017 · Cited by 67
Self-citationDesign and characterisation of new nanoparticulate polymer blends for drug delivery
Csaba, N., Gonzalez, L., Sánchez, A., & Alonso, M. J. (2004) · Journal of Biomaterials Science Polymer Edition · doi:10.1163/1568562041753098 · Cited by 67
Self-citationNeed for new vaccine formulations and potential of particulate antigen and DNA delivery systems
Friede, M., & Aguado, M. T. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.10.001 · Cited by 65
Trudel, M., Nadon, F., Séguin, C., Brault, S., Lusignan, Y., & Lemieux, S. (1992) · Vaccine · doi:10.1016/0264-410x(92)90026-g · Cited by 64
Aguado, M. T. (1993) · Vaccine · doi:10.1016/0264-410x(93)90241-o · Cited by 64
Akagi, T., Kawamura, M., Ueno, M., et al. (2002) · Journal of Medical Virology · doi:10.1002/jmv.10279 · Cited by 63
Bovine respiratory syncytial virus ISCOMs—protection in the presence of maternal antibodies
Hägglund, S., Hu, K., Larsen, L. E., Hakhverdyan, M., Valarcher, J., Taylor, G., Morein, B., Bélak, S., & Alenius, S. (2004) · Vaccine · doi:10.1016/j.vaccine.2004.07.006 · Cited by 62
Dendritic Cells and Langerhans Cells in the Uptake of Mucosal Antigens
MacPherson, G. G., & Liu, L. M. (1999) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-59951-4_3 · Cited by 62
PLA‐PEG nanospheres: new carriers for transmucosal delivery of proteins and plasmid DNA
Vila, A., Sánchez, A., Pérez, C., & Alonso, M. J. (2002) · Polymers for Advanced Technologies · doi:10.1002/pat.280 · Cited by 61
Self-citationKunisawa, J., Nakanishi, T., Takahashi, I., Okudaira, A., Tsutsumi, Y. M., Katayama, K., Nakagawa, S., Kiyono, H., & Mayumi, T. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.3.1406 · Cited by 59
Wattendorf, U., Coullerez, G., Vörös, J., Textor, M., & Merkle, H. P. (2008) · Langmuir · doi:10.1021/la801085d · Cited by 58
Miyake, A., Akagi, T., Enose, Y., Ueno, M., Kawamura, M., Horiuchi, R., Hiraishi, K., Adachi, M., Serizawa, T., Narayan, O., et al. (2004) · Journal of Medical Virology · doi:10.1002/jmv.20100 · Cited by 55
Mucociliary clearance and drug delivery via the respiratory tract
Lansley, A. B. (1993) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(93)90014-u · Cited by 55
Fernández, N., Alonso, S., Valera, I., Vigo, A., Renedo, M., Barbolla, L., & Crespo, M. S. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.12.8154 · Cited by 54
de Haan, A., Tomee, J. F. C., Huchshorn, J. P., & Wilschut, J. (1995) · Vaccine · doi:10.1016/0264-410x(95)00037-2 · Cited by 54
Synthetic biomimetic supra molecular Biovector™ (SMBV™) particles for nasal vaccine delivery
von Hoegen, P. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00175-2 · Cited by 53
Akagi, T., Kaneko, T., Kida, T., & Akashi, M. (2006) · Journal of Biomaterials Science Polymer Edition · doi:10.1163/156856206777996871 · Cited by 51
Villacrés-Eriksson, M., Behboudi, S., Morgan, A. J., Trinchieri, G., & Morein, B. (1997) · Cytokine · doi:10.1006/cyto.1996.0139 · Cited by 50
Gogev, S., de Fays, K., Versali, M.-F., Gautier, S., & Thiry, É. (2003) · Vaccine · doi:10.1016/j.vaccine.2003.11.011 · Cited by 45
Vaccine strategies to overcome maternal antibody mediated inhibition of measles vaccine
Osterhaus, A. D. M. E., van Amerongen, G., & van Binnendijk, R. (1998) · Vaccine · doi:10.1016/s0264-410x(98)00112-1 · Cited by 44
Lambkin‐Williams, R., OXFORD, J. S., Bossuyt, S., Mann, A., Metcalfe, I. C., Herzog, C., Viret, J., & Glück, R. (2004) · Vaccine · doi:10.1016/j.vaccine.2003.10.054 · Cited by 43
Thérien, H.-M., Shahum, É., & Fortin, A. (1991) · Cellular Immunology · doi:10.1016/0008-8749(91)90362-f · Cited by 39
Intranasal Influenza Vaccine in a Working Population
Sendi, P., Locher, R., Bucheli, B., & Battegay, M. (2004) · Clinical Infectious Diseases · doi:10.1086/386330 · Cited by 38
Sloat, B. R., & Cui, Z. (2005) · Pharmaceutical Research · doi:10.1007/s11095-005-9078-7 · Cited by 36
Hinkula, J., Devito, C., Zuber, B., Benthin, R., Ferreira, D. A., Wahrén, B., & Schröder, U. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.08.015 · Cited by 34
Krieg, A. Μ. (2007) · Nature Biotechnology · doi:10.1038/nbt0307-303 · Cited by 32
A new family of carriers (biovectors) enhances the immunogenicity of rabies antigens
Castignolles, N., Morgeaux, S., Jallet, C., Samain, D., Betbeder, D., & Perrin, P. (1996) · Vaccine · doi:10.1016/s0264-410x(96)00043-6 · Cited by 29
Debertin, A. S., Tschernig, T., Schürmann, A., Bajanowski, T., Brinkmann, B., & Pabst, R. (2006) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2006.03190.x · Cited by 27
ISCOM: A Delivery System for Neonates and for Mucosal Administration
Morein, B., Villacrés-Eriksson, M., Ekström, J., et al. (1999) · Advances in veterinary medicine · doi:10.1016/s0065-3519(99)80030-5 · Cited by 25
Nanosphere Induced Gene Expression in Human Dendritic Cells
Matsusaki, M., Larsson, K., Akagi, T., Lindstedt, M., Akashi, M., & Borrebaeck, C. A. K. (2005) · Nano Letters · doi:10.1021/nl050541s · Cited by 25
Akagi, T., Ueno, M., Hiraishi, K., Baba, M., & Akashi, M. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.09.014 · Cited by 24
Koopman, G., Bogers, W. M. J. M., van Gils, M. J., Koornstra, W., Barnett, S. W., Morein, B., Lehner, T., & Heeney, J. L. (2007) · Journal of Medical Virology · doi:10.1002/jmv.20860 · Cited by 24
Lian, T., Bui, T., & Ho, R. J. Y. (1999) · Vaccine · doi:10.1016/s0264-410x(99)00315-1 · Cited by 23
Bråve, A., Hallengärd, D., Schröder, U., Blomberg, P., Wahrén, B., & Hinkula, J. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.03.066 · Cited by 23
Kawamura, M., Wang, X., Uto, T., et al. (2005) · Journal of Medical Virology · doi:10.1002/jmv.20317 · Cited by 19
Immunotherapy for Alzheimer's Disease and Other Dementias
Boche, D., Nicoll, J. A. R., & Weller, R. O. (2006) · Clinical Neuropharmacology · doi:10.1097/00002826-200601000-00008 · Cited by 10
An update on the prevention of influenza in children and adolescents
Heininger, U. (2003) · European Journal of Pediatrics · doi:10.1007/s00431-003-1324-6 · Cited by 5
Cited by
Motornov, M., Roiter, Y., Tokarev, I., & Minko, S. (2010) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2009.10.004 · Cited by 773
Current State of Nanoemulsions in Drug Delivery
Lovelyn, C., & Attama, A. A. (2011) · Journal of Biomaterials and Nanobiotechnology · doi:10.4236/jbnb.2011.225075 · Cited by 411
Recent advances in carrier mediated nose-to-brain delivery of pharmaceutics
Bourganis, V., Kammona, O., Alexopoulos, A., & Kiparissides, C. (2018) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2018.05.009 · Cited by 357
Nanoemulsion: An Emerging Novel Technology for Improving the Bioavailability of Drugs
Preeti, Sambhakar, S., Malik, R., Bhatia, S., Al Harrasi, A., Rani, C., Saharan, R., Kumar, S., Geeta, & Sehrawat, R. (2023) · Scientifica · doi:10.1155/2023/6640103 · Cited by 331
Nanoparticle-Based Vaccines Against Respiratory Viruses
Al-Halifa, S., Gauthier, L., Arpin, D., Bourgault, S., & Archambault, D. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00022 · Cited by 299
Metadata
- Authors
- Csaba, N., Garcia-Fuentes, M., & Alonso, M. J.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2009-02
- Volume
- 61
- Issue
- 2
- Pages
- 140-157
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W2016471012
- Cited by
- 277
- References
- 177
- FWCI
- 1.07
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.